• HIV Web Study
  • Case-Based Modules
  • Initial Evaluation
  • Dermatologic Manifestations
  • Oral Manifestations
  • OIs: Prophylaxis
  • OIs: Treatment
  • Antiretroviral Rx
  • Antiretroviral Rx: Resistance
  • Antiretroviral Rx: Adverse Effects
  • Drug-Drug Interactions
  • Postexposure Prophylaxis
  • Perinatal Transmission
  • Special Populations
  • Prevention for Positives
  • Challenging Unknowns
  • Resource-Limited Settings
  • Interactive Tutorials
  • Routine HIV Screening
  • Oraquick Advance Rapid HIV Test
  • HIV Integration
  • This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
  • Home
  • About This Site
  • Free CE
  • AETC NRC
  • Resources
  • Feedback
  • Site Map
  • Authors

Antiretroviral Rx: Resistance

  • Case 1: Indications for Resistance Testing
  • Case 2: Features of Genotypic and Phenotypic Resistance Assays
  • Case 3: Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors
  • Case 4: Resistance to Nelfinavir

Disclaimer | Privacy Policy Copyright © 2004-2013 University of Washington